Form 4: ADMA Biologics COO Kaitlin Kestenberg-Messina Reports Tax Withholding on RSU Vesting

Kaitlin Kestenberg-Messina, COO and SVP of Compliance at ADMA Biologics, reports the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Summary

• On July 24, 2024, Kaitlin Kestenberg-Messina, COO and SVP of Compliance at ADMA Biologics, had 2,502 shares of common stock withheld by the issuer to satisfy tax obligations related to the vesting of restricted stock units (RSUs).
• The shares were withheld at a price of $13.58 per share.
• Following the transaction, Kestenberg-Messina beneficially owns 449,088 shares of ADMA Biologics, which includes unvested RSUs and shares of common stock.

Sentiment

Score: 5

Explanation: This is a neutral event related to tax obligations on vested RSUs; it doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it reflects tax obligations related to executive compensation.

Key Dates